AmoyDx and CST Expand Existing Partnership for the Developme

Cell Signaling Technology (CST), a life science biotechnology company and leading provider of antibodies, kits, and services, and Amoy Diagnostics Co., Ltd. (AmoyDx), a China-based innovative molecular diagnostics company in the field of precision oncology, announced today the expansion of their ongoing partnership for companion diagnostic (CDx) development in China.

Related Keywords

Japan , China , Massachusetts , United States , Amoy , Fujian , South Korea , Roberto Polakiewicz , Jiemin Luo , Cell Signaling Technology , Supplier Succeeding In Cancer Research , Amoy Diagnostics Co Ltd , Chief Scientific Officer , Detection Kit , General Manager , Supplier Succeeding , Cancer Research , Signaling Technology , Diagnostics , Ncology , Antibodies , Ntibody , Biotechnology , Dancer , Arcinoma , Fell , Cell Signaling , Iagnostic , Hc , Life Science , Molecular Diagnostics , Pd L1 , Research , Technology , Herapeutics ,